The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Sphingolipid metabolism diseases
Open accessAbstract
Human diseases caused by alterations in the metabolism of sphingolipids or glycosphingolipids are mainly disorders of the degradation of these compounds. The sphingolipidoses are a group of monogenic inherited diseases caused by defects in the system of lysosomal sphingolipid degradation, with subsequent accumulation of non-degradable storage material in one or more organs. Most sphingolipidoses are associated with high mortality. Both, the ratio of substrate influx into the lysosomes and the reduced degradative capacity can be addressed by therapeutic approaches. In addition to symptomatic treatments, the current strategies for restoration of the reduced substrate degradation within the lysosome are enzyme replacement therapy (ERT), cell-mediated therapy (CMT) including bone marrow transplantation (BMT) and cell-mediated "cross correction", gene therapy, and enzyme-enhancement therapy with chemical chaperones. The reduction of substrate influx into the lysosomes can be achieved by substrate reduction therapy. Patients suffering from the attenuated form (type 1) of Gaucher disease and from Fabry disease have been successfully treated with ERT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Biological roles of oligosaccharides: all of the theories are correct
Varki, A. (1993) · Glycobiology · doi:10.1093/glycob/3.2.97 · Cited by 5,195
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts
Brown, D. A., & London, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000005200 · Cited by 2,344
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Maxfield, F. R., & McGraw, T. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1315 · Cited by 1,729
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Glycosphingolipids in Cellular Interaction, Differentiation, and Oncogenesis
Hakomori, S. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.003505 · Cited by 1,644
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450102 · Cited by 1,559
Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,514
(1964) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,409
Enzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Schiffmann, R., Kopp, J. B., Austin III, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001) · JAMA · doi:10.1001/jama.285.21.2743 · Cited by 1,302
Molecular machinery for non-vesicular trafficking of ceramide
Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., & Nishijima, M. (2003) · Nature · doi:10.1038/nature02188 · Cited by 1,051
Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes
Reddy, A., Caler, E. V., & Andrews, N. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00421-4 · Cited by 1,042
Lysosomal Glycosphingolipid Recognition by NKT Cells
Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., et al. (2004) · Science · doi:10.1126/science.1103440 · Cited by 956
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Hollak, C. E., van Weely, S., van Oers, M. H., & Aerts, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117084 · Cited by 896
Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's disease
Brady, R. O., Kanfer, J. N., & Shapiro, D. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90743-6 · Cited by 807
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
A lipid associated with the antiphospholipid syndrome regulates endosome structure and function
Kobayashi, T., Stang, E., Fang, K. S., de Moerloose, P., Parton, R. G., & Gruenberg, J. (1998) · Nature · doi:10.1038/32440 · Cited by 787
Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebícek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02161-9 · Cited by 744
Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease
Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042604 · Cited by 709
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694
ANIMAL GLYCOSPHINGOLIPIDS AS MEMBRANE ATTACHMENT SITES FOR BACTERIA
Karlsson, K.-A. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001521 · Cited by 683
At the acidic edge: emerging functions for lysosomal membrane proteins
Eskelinen, E.-L., Tanaka, Y., & Saftig, P. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00005-9 · Cited by 660
De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway
Merrill, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200009200 · Cited by 617
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
α-Galactosidase A deficiency. Fabry disease
Desnick, R. J. (2001) · Cited by 605
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Self-citationBruyn, R. P. M. (2003) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00110-5 · Cited by 509
A vital role for glycosphingolipid synthesis during development and differentiation
Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., & Proia, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9142 · Cited by 505
Self-citationSawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Detergent-resistant membranes should not be identified with membrane rafts
Lichtenberg, D., Goñi, F. M., & Heerklotz, H. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.06.004 · Cited by 490
Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease
Horinouchi, K., Erlich, S., Perl, D. P., Ferlinz, K., Bisgaier, C. L., Sandhoff, K., Desnick, R. J., Stewart, C. L., & Schuchman, E. H. (1995) · Nature Genetics · doi:10.1038/ng0795-288 · Cited by 471
Self-citationSango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468
Self-citationKolter, T., & Sandhoff, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120013 · Cited by 464
Self-citationGloboid Cell Leucodystrophy (Krabbe's Disease): Deficiency of Galactocerebroside β-Galactosidase
Suzuki, K., & Suzuki, Y. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.66.2.302 · Cited by 459
Möbius, W., Van Donselaar, E., Ohno‐Iwashita, Y., Shimada, Y., Heijnen, H. F. G., Slot, J. W., & Geuze, H. J. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00072.x · Cited by 453
Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling
Chalfant, C. E., & Spiegel, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.02637 · Cited by 444
Ceramide: second messenger or modulator of membrane structure and dynamics?
BLITTERSWIJK, W. J. V., LUIT, A. H. V. D., VELDMAN, R. J., VERHEIJ, M., & BORST, J. (2003) · Biochemical Journal · doi:10.1042/bj20021528 · Cited by 435
Dawkins, J. L., Hulme, D. J., Brahmbhatt, S. B., Auer-Grumbach, M., & Nicholson, G. A. (2001) · Nature Genetics · doi:10.1038/85879 · Cited by 423
Wada, R., Tifft, C. J., & Proia, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10954 · Cited by 403
Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., et al. (2004) · Nature Genetics · doi:10.1038/ng1460 · Cited by 389
Sphingolipids—Their Metabolic Pathways and the Pathobiochemistry of Neurodegenerative Diseases
Kolter, T., & Sandhoff, K. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1532::aid-anie1532>3.0.co;2-u · Cited by 386
Self-citationDierks, T., Schmidt, B., Borissenko, L. V., Peng, J., Preusser, A., Mariappan, M., & von Figura, K. (2003) · Cell · doi:10.1016/s0092-8674(03)00347-7 · Cited by 386
α-Galactosidase A deficient mice: A model of Fabry disease
Ohshima, T., Murray, G. J., Swaim, W. D., Longenecker, G., Quirk, J. M., Cardarelli, C. O., Sugimoto, Y., Pastan, I., Gottesman, M. M., Brady, R. O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2540 · Cited by 367
Barton, N. W., Furbish, F. S., Murray, G. J., Garfield, M., & Brady, R. O. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1913 · Cited by 366
A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency
Schmidt, B., Selmer, T., Ingendoh, A., & Figurat, K. V. (1995) · Cell · doi:10.1016/0092-8674(95)90314-3 · Cited by 361
Intracellular signal transduction pathways activated by ceramide and its metabolites
Ruvolo, P. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00050-1 · Cited by 355
Jeyakumar, M. (2003) · Brain · doi:10.1093/brain/awg089 · Cited by 352
Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N -Butyldeoxynojirimycin
Platt, F. M., Neises, G. R., Reinkensmeier, G., Townsend, M. J., Perry, V. H., Proia, R. L., Winchester, B., Dwek, R. A., & Butters, T. D. (1997) · Science · doi:10.1126/science.276.5311.428 · Cited by 340
Frustaci, A., Chimenti, C., Ricci, R., Natale, L., Russo, M. A., Pieroni, M., Eng, C. M., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450104 · Cited by 332
Leinekugel, P., Michel, S., Conzelmann, E., & Sandhoff, K. (1992) · Human Genetics · doi:10.1007/bf00219337 · Cited by 327
Self-citationInfectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes
Yuki, N. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00019-6 · Cited by 326
Combinatorial Ganglioside Biosynthesis
Kolter, T., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200001200 · Cited by 322
Self-citationEditing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins
Zhou, D., Cantu, C., Sagiv, Y., Schrantz, N., Kulkarni, A. B., Qi, X., Mahuran, D. J., Morales, C. R., Grabowski, G. A., Benlagha, K., et al. (2004) · Science · doi:10.1126/science.1092009 · Cited by 312
Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
Tybulewicz, V. L. J., Tremblay, M. L., LaMarca, Willemsen, R., Stubblefield, B. K., Winfield, S., Zablocka, B., Sidransky, E., Martin, B. M., Huang, S. P., et al. (1992) · Nature · doi:10.1038/357407a0 · Cited by 308
Möbius, W., Ohno-Iwashita, Y., Donselaar, E. G. V., Oorschot, V. M. J., Shimada, Y., Fujimoto, T., Heijnen, H. F. G., Geuze, H. J., & Slot, J. W. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000105 · Cited by 302
The biological role of dolichol
Chojnacki, T., & Dallner, G. (1988) · Biochemical Journal · doi:10.1042/bj2510001 · Cited by 300
α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles
Kaer, L. V. (2005) · Nature Reviews Immunology · doi:10.1038/nri1531 · Cited by 299
Gangliosides are neuronal ligands for myelin-associated glycoprotein.
Yang, L. J., Zeller, C. B., Shaper, N. L., Kiso, M., Hasegawa, A., Shapiro, R. E., & Schnaar, R. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.814 · Cited by 295
Vellodi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05293.x · Cited by 295
ENZYME ALTERATIONS AND LIPID STORAGE IN THREE VARIANTS OF TAY‐SACHS DISEASE
Sandhoff, K., Harzer, K., Wässle, W., & Jatzkewitz, H. (1971) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1971.tb00204.x · Cited by 293
Self-citationLysosome-endosome fusion and lysosome biogenesis
Luzio, J. P., Rous, B. A., Bright, N. A., Pryor, P. R., Mullock, B. M., & Piper, R. C. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.9.1515 · Cited by 292
Molecular Basis of Different Forms of Metachromatic Leukodystrophy
Polten, A., Fluharty, A. L., Fluharty, C. B., Kappler, J., von Figura, K., & Gieselmann, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240104 · Cited by 292
Gaucher disease: pathological mechanisms and modern management
Jmoudiak, M., & Futerman, A. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05351.x · Cited by 288
Nilsson, O., & Svennerholm, L. T. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb07950.x · Cited by 283
Biffi, A., De Palma, M., Quattrini, A., Del Carro, U., Amadio, S., Visigalli, I., Sessa, M., Fasano, S., Brambilla, R., Marchesini, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419205 · Cited by 280
Eine Cerebrosidsulfatase aus Schweineniere
Mehl, E., & Jatzkewitz, H. (1964) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1964.339.1.260 · Cited by 279
X‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease
Dvir, H., Harel, M., McCarthy, A. A., Toker, L., Silman, I., Futerman, A. H., & Sussman, J. L. (2003) · EMBO reports · doi:10.1038/sj.embor.embor873 · Cited by 278
Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease
Purpura, D. P., & Suzuki, K. (1976) · Brain Research · doi:10.1016/0006-8993(76)90245-6 · Cited by 277
Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin
Sandvig, K., & van Deurs, B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03182-4 · Cited by 276
Conzelmann, E., & Sandhoff, K. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3979 · Cited by 275
Self-citationKrivit, W., Peters, C., & Shapiro, E. G. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199904000-00007 · Cited by 273
Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological Disorders
Conzelmann, E., & Sandhoff, K. (2009) · Developmental Neuroscience · doi:10.1159/000112332 · Cited by 272
Self-citationEnzyme replacement and enhancement therapies: lessons from lysosomal disorders
Desnick, R. J., & Schuchman, E. H. (2002) · Nature Reviews Genetics · doi:10.1038/nrg963 · Cited by 268
Activator proteins and topology of lysosomal sphingolipid catabolism
Fürst, W., & Sandhoff, K. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90210-m · Cited by 267
Self-citationPhenotype of arylsulfatase A-deficient mice: Relationship to human metachromatic leukodystrophy
Hess, B., Saftig, P., Hartmann, D., Coenen, R., Lüllmann-Rauch, R., Goebel, H. H., Evers, M., von Figura, K., D’Hooge, R., Nagels, G., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14821 · Cited by 264
6-Hydroxy-4-sphingenine in human epidermal ceramides.
Robson, K. J., Stewart, M. E., Michelsen, S., Lazo, N. D., & Downing, D. T. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39952-1 · Cited by 263
Chemical chaperone therapy for brain pathology in G M1 -gangliosidosis
Matsuda, J., Suzuki, O., Oshima, A., Yamamoto, Y., Noguchi, A., Takimoto, K., Itoh, M., Matsuzaki, Y., Yasuda, Y., Ogawa, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536657100 · Cited by 262
Biffi, A., De Palma, M., Quattrini, A., Del Carro, U., Amadio, S., Visigalli, I., Sessa, M., Fasano, S., Brambilla, R., Marchesini, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19205 · Cited by 261
Specific gangliosides function as host cell receptors for Sendai virus.
Markwell, M. A., Svennerholm, L., & Paulson, J. C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5406 · Cited by 259
Gaucher's Disease: Deficiency of “cid”β-Glucosidase and Reconstitution of Enzyme Activity In Vitro
Ho, M. W., & O'Brien, J. S. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.11.2810 · Cited by 257
Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus
Natori, T., Koezuka, Y., & Higa, T. (1993) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)73889-5 · Cited by 253
Koch, J., Gärtner, S., Li, C.-M., Quintern, L. E., Bernardo, K., Levran, O., Schnabel, D., Desnick, R. J., Schuchman, E. H., & Sandhoff, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.33110 · Cited by 249
Self-citationCoding of Two Sphingolipid Activator Proteins (SAP-1 and SAP-2) by Same Genetic Locus
O'Brien, J. S., Kretz, K. A., Dewji, N., Wenger, D. A., Esch, F., & Fluharty, A. L. (1988) · Science · doi:10.1126/science.2842863 · Cited by 247
A Deficiency of Glucocerebrosidase in Gaucher's Disease
Patrick, A. D. (1965) · Biochemical Journal · doi:10.1042/bj0970017c · Cited by 246
Hurwitz, R., Ferlinz, K., & Sandhoff, K. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.7.447 · Cited by 244
Self-citationAsano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O. R., & Fan, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01457.x · Cited by 242
Elstein, D., Hollak, C., Aerts, J. M. F. G., van Weely, S., Maas, M., Cox, T. M., Lachmann, R. H., Hrebicek, M., Platt, F. M., Butters, T. D., et al. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000045756.54006.17 · Cited by 234
Sphingolipid Transport: Rafts and Translocators
van Meer, G., & Lisman, Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200010200 · Cited by 233
A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity
Fan, J.-Q. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00158-5 · Cited by 232
The physical, chemical and functional properties of lipids in the skin and other biological barriers
Wertz, P. W., & van den Bergh, B. (1998) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(97)00108-4 · Cited by 230
Tessitore, A., del P. Martin, M., Sano, R., Ma, Y., Mann, L., Ingrassia, A., Laywell, E. D., Steindler, D. A., Hendershot, L. M., & d'Azzo, A. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.029 · Cited by 225
Mark, B. L., Mahuran, D. J., Cherney, M. M., Zhao, D., Knapp, S., & James, M. N. G. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00216-x · Cited by 223
Enzyme replacement and enhancement therapies for lysosomal diseases
Desnick, R. J. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000031101.12838.c6 · Cited by 222
Kytzia, H. J., & Sandhoff, K. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39645-x · Cited by 220
Self-citationImino sugar inhibitors for treating the lysosomal glycosphingolipidoses
Butters, T. D., Dwek, R. A., & Platt, F. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi076 · Cited by 218
Ceramides Are Bound to Structural Proteins of the Human Foreskin Epidermal Cornified Cell Envelope
Marekov, L. N., & Steinert, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17763 · Cited by 217
Fujita, N. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.711 · Cited by 217
Purification, Characterization, and Biosynthesis of Human Acid Ceramidase
Bernardo, K., Hurwitz, R., Zenk, T., Desnick, R. J., Ferlinz, K., Schuchman, E. H., & Sandhoff, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11098 · Cited by 214
Self-citationGanglioside/glycosphingolipid turnover: New concepts
Tettamanti, G. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000033627.02765.cc · Cited by 213
Otterbach, B., & Stoffel, W. (1995) · Cell · doi:10.1016/s0092-8674(05)80010-8 · Cited by 209
Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells
Kang, S.-J., & Cresswell, P. (2004) · Nature Immunology · doi:10.1038/ni1034 · Cited by 206
Harzer, K., Paton, B. C., Poulos, A., Kustermann-Kuhn, B., Roggendorf, W., Grisar, T., & Popp, M. (1989) · European Journal of Pediatrics · doi:10.1007/bf02024331 · Cited by 199
Kölzer, M., Werth, N., & Sandhoff, K. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00033-x · Cited by 198
Self-citationTropak, M. B., Reid, S. P., Guiral, M., Withers, S. G., & Mahuran, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308523200 · Cited by 197
Storage solutions: treating lysosomal disorders of the brain
Jeyakumar, M., Dwek, R. A., Butters, T. D., & Platt, F. M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1725 · Cited by 192
Sakai, N., Inui, K., Tatsumi, N., Fukushima, H., Nishigaki, T., Taniike, M., Nishimoto, J., Tsukamoto, H., Yanagihara, I., Ozono, K., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66031118.x · Cited by 190
Identification of a Molecular Target of Psychosine and Its Role in Globoid Cell Formation
Im, D.-S., Heise, C. E., Nguyen, T., O'Dowd, B. F., & Lynch, K. R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.429 · Cited by 190
Birkenmeier, E., Barker, J., Vogler, C., Kyle, J., Sly, W., Gwynn, B., Levy, B., & Pegors, C. (1991) · Blood · doi:10.1182/blood.v78.11.3081.3081 · Cited by 184
Korkotian, E., Schwarz, A., Pelled, D., Schwarzmann, G., Segal, M., & Futerman, A. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21673 · Cited by 183
Crystal structure of saposin B reveals a dimeric shell for lipid binding
Ahn, V. E., Faull, K. F., Whitelegge, J. P., Fluharty, A. L., & Privé, G. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136947100 · Cited by 182
Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice
Wu, Y.-P., & Proia, R. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400625101 · Cited by 182
CONZELMANN, E., & SANDHOFF, K. (1979) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1979.360.2.1837 · Cited by 179
Self-citationHahn, C. N., del Pilar Martin, M., Schroder, M., Vanier, M. T., Suzuki, K., Hara, Y., Suzuki, K., & d'Azzo, A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.205 · Cited by 173
[Niemann-Pick disease [type A and B] (acid sphingomyelinase deficiencies)].
Higaki, K., & OHNO, K. (1998) · PubMed · Cited by 172
Viable Mouse Models of Acid β-Glucosidase Deficiency
Xu, Y.-H., Quinn, B., Witte, D., & Grabowski, G. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63566-3 · Cited by 170
Krivit, W. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0166-2 · Cited by 170
Saposin C is required for lipid presentation by human CD1b
Winau, F., Schwierzeck, V., Hurwitz, R., Remmel, N., Sieling, P. A., Modlin, R. L., Porcelli, S. A., Brinkmann, V., Sugita, M., Sandhoff, K., et al. (2004) · Nature Immunology · doi:10.1038/ni1035 · Cited by 168
Self-citationYam, G. H.-F., Zuber, C., & Roth, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2375com · Cited by 163
Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease
Schnabel, D., Schröder, M., & Sandhoff, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80760-z · Cited by 162
Self-citationTopology of glycosphingolipid degradation
Sandhoff, K., & Kolter, T. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)80999-8 · Cited by 162
Self-citationNorflus, F., Tifft, C. J., McDonald, M. P., Goldstein, G., Crawley, J. N., Hoffmann, A., Sandhoff, K., Suzuki, K., & Proia, R. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2127 · Cited by 160
Self-citationA genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder
Liu, Y., Wada, R., Kawai, H., Sango, K., Deng, C., Tai, T., McDonald, M. P., Araujo, K., Crawley, J. N., Bierfreund, U., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5542 · Cited by 160
Self-citationEckford, P. D. W., & Sharom, F. J. (2005) · Biochemical Journal · doi:10.1042/bj20050047 · Cited by 157
Lysosomal Degradation on Vesicular Membrane Surfaces
Wilkening, G., Linke, T. A., & Sandhoff, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30271 · Cited by 156
Self-citationSphingolipid Activator Protein D (sap-D) Stimulates the Lysosomal Degradation of Ceramide in Vivo
Klein, A., Henseler, M., Klein, C., Suzuki, K., HARZER, K., & Sandhoff, K. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1612 · Cited by 154
Self-citationPohlentz, G., KLEIN, D., Schwarzmann, G. O. H., Schmitz, D. W., & Sandhoff, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7044 · Cited by 154
Self-citationChristomanou, H., Aignesberger, A., & LINKE, R. P. (1986) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1986.367.2.879 · Cited by 154
TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASE
Ringdén, O. T. H., Groth, C. G., Erikson, A., Granqvist, S., Månsson, J., & Sparrelid, E. (1995) · Transplantation · doi:10.1097/00007890-199503000-00011 · Cited by 153
Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
Mizukami, H., Mi, Y.-D., Wada, R., Kono, M., Yamashita, T., Liu, Y.-J., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14530 · Cited by 153
Self-citationMatsuda, J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.11.1191 · Cited by 151
Matzner, U., Herbst, E., Hedayati, K. K., Lüllmann‐Rauch, R., Wessig, C., Schröder, S., Eistrup, C., Möller, C., Fogh, J. M., & Gieselmann, V. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi126 · Cited by 149
Schnabel, D., Schröder, M., Fürst, W., Klein, A., HURWITZ, R. M., Zenk, T. S., Weber, J., HARZER, K., Paton, B. C., & Poulos, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50733-5 · Cited by 148
Elevated Levels of M-CSF, sCD14 and IL8 in Type 1 Gaucher Disease
Hollak, C. E. M., Evers, L. M., Aerts, J. M. F. G., & van Oers, M. H. J. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0137 · Cited by 148
The Reverse Activity of Human Acid Ceramidase
Okino, N., He, X., Gátt, S., Sandhoff, K., Ito, M., & Schuchman, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303310200 · Cited by 147
Self-citationCellular Pathology of Lysosomal Storage Disorders
Walkley, S. U. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00144.x · Cited by 145
Broad screening test for sphingolipid-storage diseases
Chen, C.-S., Patterson, M. C., O’Brien, J. F., Pagano, R. E., & Wheatley, C. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10034-x · Cited by 136
Sphingosylphosphorylcholine—biological functions and mechanisms of action
zu Heringdorf, D. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00154-3 · Cited by 135
Gene therapy for lysosomal storage diseases: the lessons and promise of animal models
Ellinwood, N. M., Vite, C. H., & Haskins, M. E. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.581 · Cited by 135
Charria-Ortiz, G. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-70909-3_16 · Cited by 132
Lysosomal multienzyme complex: Biochemistry, genetics, and molecular pathophysiology
Pshezhetsky, A. V., & Ashmarina, M. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)69045-7 · Cited by 131
Passini, M. A., Lee, E. B., Heuer, G. G., & Wolfe, J. H. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06437.2002 · Cited by 131
Analyses of Variant Acid β-Glucosidases
Liou, B., Kazimierczuk, A., Zhang, M., Scott, C. R., Hegde, R. S., & Grabowski, G. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511110200 · Cited by 130
Nakano, T., Sandhoff, K., Stumper, J., Christomanou, H., & Suzuki, K. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122629 · Cited by 130
Self-citationSpiegel, R., Bach, G., Sury, V., Mengistu, G., Meidan, B., Shalev, S., Shneor, Y., Mandel, H., & Zeigler, M. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.10.004 · Cited by 129 · cited 8×
“Sap-A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2068 3.12.3.”
BackgroundInfluentialInterfacial Regulation of Acid Ceramidase Activity
Linke, T. A., Wilkening, G., Sadeghlar, F., Mozcall, H., Bernardo, K., Schuchman, E. H., & Sandhoff, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006846200 · Cited by 126
Self-citationProsaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs
Bradová, V., Šmíd, F., Ulrich‐Bott, B., Roggendorf, W., Paton, B. C., & HARZER, K. (1993) · Human Genetics · doi:10.1007/bf00219682 · Cited by 126
Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage
Mizukami, H., Mi, Y., Wada, R., Kono, M., Yamashita, T., Liu, Y., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214530 · Cited by 125
Self-citationKrivit, W. A., Aubourg, P. R., Shapiro, E., & Peters, C. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199911000-00004 · Cited by 123
Linke, T. A., Wilkening, G., Lansmann, S., Moczall, H., Bartelsen, O., Weisgerber, J., & Sandhoff, K. (2001) · Biological Chemistry · doi:10.1515/bc.2001.035 · Cited by 122
Self-citationNSAIDs increase survival in the Sandhoff disease mouse: Synergy with N‐butyldeoxynojirimycin
Jeyakumar, M., Smith, D. A., Williams, I. M., Cortina‐Borja, M., Neville, D. C. A., Butters, T. D., Dwek, R. A., & Platt, F. M. (2004) · Annals of Neurology · doi:10.1002/ana.20242 · Cited by 122
X-ray Structure of Human Acid-β-Glucosidase Covalently Bound to Conduritol-B-Epoxide
Premkumar, L., Sawkar, A. R., Boldin‐Adamsky, S., Toker, L., Silman, I., Kelly, J. W., Futerman, A. H., & Sussman, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502799200 · Cited by 118
Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz, K. A., Carson, G. S., Morimoto, S., Kishimoto, Y., Fluharty, A. L., & O'Brien, J. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2541 · Cited by 118
The X-ray Crystal Structure of Human β-Hexosaminidase B Provides New Insights into Sandhoff Disease
Maier, T., Sträter, N., Schuette, C. G., Klingenstein, R., Sandhoff, K., & Saenger, W. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00311-5 · Cited by 117
Self-citationRafi, M. A., Luzi, P., Chen, Y. Q., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1285 · Cited by 117
Li, C.-M., Park, J., Simonaro, C. M., He, X., Gordon, R. E., Friedman, A.-H., Ehleiter, D., Paris, F., Manova, K., Hepbiloikler, S., et al. (2002) · Genomics · doi:10.1006/geno.2002.6686 · Cited by 117
Self-citationInhibition of Cytokinesis by a Lipid Metabolite, Psychosine
Kanazawa, T., Nakamura, S., Momoi, M., Yamaji, T., Takematsu, H., Yano, H., Sabe, H., Yamamoto, A., Kawasaki, T., & Kozutsumi, Y. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.4.943 · Cited by 114
Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis
Rosa, M. F. D., Sillence, D. J., Ackerley, C. A., & Lingwood, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305645200 · Cited by 114
Wu, G., Lu, Z., Wang, J., Wang, Y., Xie, X., MEYENHOFER, M. F., & Ledeen, R. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3635-05.2005 · Cited by 114
Mechanism of activation of glucocerebrosidase by CO-β-glucosidase (glucosidase activator protein)
Berent, S. L., & Radin, N. S. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90134-x · Cited by 113
Hůlková, H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.927 · Cited by 113
Taniike, M., Mohri, I., Eguchi, N., Irikura, D., Urade, Y., Okada, S., & Suzuki, K. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199906000-00009 · Cited by 111
Yoshida, K., Oshima, A., Shimmoto, M., Fukuhara, Y., Sakuraba, H., Yanagisawa, N., & Suzuki, Y. (1991) · Europe PMC (PubMed Central) · Cited by 110
The Precursor of Sulfatide Activator Protein is Processed to Three Different Proteins
Fürst, W., Machleidt, W., & Sandhoff, K. (1988) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1988.369.1.317 · Cited by 110
Self-citationLi, S. C., Kihara, H. K., Serizawa, S., Li, Y. T., Fluharty, A. L., Mayes, J. S., & Shapiro, L. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89673-9 · Cited by 108
Bioorganic Chemistry of Ceramide
Brodesser, S., Sawatzki, P., & Kolter, T. (2003) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200200518 · Cited by 107
Self-citationOhashi, T., Watabe, K., Uehara, K., Sly, W. S., Vogler, C. A., & Eto, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1287 · Cited by 107
Ganglioside Glycosyltransferases Organize in Distinct Multienzyme Complexes in CHO-K1 Cells
Giraudo, C. G., & Maccioni, H. J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305455200 · Cited by 103
Lysosomal Disorders of the Brain
(2004) · doi:10.1093/acprof:oso/9780198508786.001.0001 · Cited by 103
Sphingosylphosphorylcholine in Niemann-Pick Disease Brain: Accumulation in Type A But Not in Type B
Rodriguez‐Lafrasse, C., & Vanier, M. T. (1999) · Neurochemical Research · doi:10.1023/a:1022501702403 · Cited by 100
Gaucher disease: perspectives on a prototype lysosomal disease
Zhao, H., & Grabowski, G. A. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8458-y · Cited by 100
Orviský, E., Sidransky, E., McKinney, C. E., LaMarca, M. E., Samimi, R., Krasnewich, D. M., Martin, B. M., & Ginns, E. I. (2000) · Pediatric Research · doi:10.1203/00006450-200008000-00018 · Cited by 99
Hobbs, J. R., Shaw, P. J., Jones, K. H., Lindsay, I., & Hancock, M. L. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91673-4 · Cited by 97
Sphingolipid Activator Proteins
Nettersheim, M., & Sandhoff, K. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0540 · Cited by 94
Self-citationHoogerbrugge, P. M., Poorthuis, B. J. H. M., Romme, A. E., van de Kamp, J. J., Wagemaker, G., & van Bekkum, D. W. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113521 · Cited by 94
Matsuda, J., Kido, M., Tadano‐Aritomi, K., Ishizuka, I., Tominaga, K., Toida, K., Takeda, E., Suzuki, K., & Kuroda, Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh281 · Cited by 94
Degradation of Membrane-bound Ganglioside GM1
Wilkening, G., Linke, T. A., Uhlhorn-Dierks, G., & Sandhoff, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006568200 · Cited by 93
Self-citationLee, C. W., Courtenay, A., Troendle, F. J., Stallings‐Mann, M. L., Dickey, C. A., DeLucia, M. W., Dickson, D. W., & Eckman, C. B. (2005) · The FASEB Journal · doi:10.1096/fj.05-3826fje · Cited by 93
Sphingolipids in Infectious Diseases
Hanada, K. (2005) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2005.131 · Cited by 93
Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids.
Li, S. C., Sonnino, S., Tettamanti, G., & Li, Y. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68681-8 · Cited by 92
Utermöhlen, O., Karow, U., Löhler, J., & Krönke, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2621 · Cited by 89
Endoplasmic reticulum-associated protein degradation
Jarosch, E., Lenk, U., & Sommer, T. (2002) · International review of cytology · doi:10.1016/s0074-7696(05)23002-4 · Cited by 88
Park, J., Murray, G. J., Limaye, A., Quirk, J. M., Gelderman, M. P., Brady, R. O., & Qasba, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0537900100 · Cited by 88
Molecular analysis of acid ceramidase deficiency in patients with Farber disease
Bär, J., Linke, T. A., Ferlinz, K., Neumann, U., Schuchman, E. H., & Sandhoff, K. (2001) · Human Mutation · doi:10.1002/humu.5 · Cited by 88
Self-citationRecent Advances in the Biochemistry of Sphingolipidoses
Kolter, T., & Sandhoff, K. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00138.x · Cited by 88
Self-citationThe CLN9 Protein, a Regulator of Dihydroceramide Synthase
Schulz, A., Mousallem, T. I., Venkataramani, M., Persaud‐Sawin, D., Zucker, A., Luberto, C., Bielawska, A. E., Bielawski, J., Holthuis, J. C. M., Jazwinski, S. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509483200 · Cited by 88
IL-6 and TNFα expression in brains of twitcher, quaking and normal mice
LeVine, S. M., & Brown, D. C. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00166-x · Cited by 87
The pathogenesis of glycosphingolipid storage disorders
Ginzburg, L., Kacher, Y., & Futerman, A. H. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.03.003 · Cited by 87
Solution Structure of Human Saposin C: pH-Dependent Interaction with Phospholipid Vesicles
de Alba, E., Weiler, S., & Tjandra, N. (2003) · Biochemistry · doi:10.1021/bi0301338 · Cited by 87
Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency
Rafi, M. A., de Gala, G., Zhang, X.-L., & Wenger, D. A. (1993) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233949 · Cited by 86
Physiological Substrates for Human Lysosomal β-Hexosaminidase S
Hepbildikler, S. T., Sandhoff, R., Kölzer, M., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105457200 · Cited by 86
Self-citationA Riddle Wrapped in a Mystery: Understanding Niemann-Pick Disease, Type C
Patterson, M. C. (2003) · The Neurologist · doi:10.1097/01.nrl.0000094627.78754.5b · Cited by 85
Bejaoui, K., Uchida, Y., Yasuda, S., Ho, M., Nishijima, M., Brown, R. H., Holleran, W. M., & Hanada, K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16450 · Cited by 85
Glycosphingolipid specifity of the human sulfatide activator protein
VOGEL, A., Schwarzmann, G. O. H., & Sandhoff, K. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16222.x · Cited by 82
Self-citationAndersson-Hall, U. K., Smith, D. A., Jeyakumar, M., Butters, T. D., Cortina‐Borja, M., Dwek, R. A., & Platt, F. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.012 · Cited by 81
Bejaoui, K., Uchida, Y., Yasuda, S., Ho, M., Nishijima, M., Brown, R. H., Holleran, W. M., & Hanada, K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216450 · Cited by 81
Stein, C. S., Ghodsi, A., Derksen, T. A., & Davidson, B. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3424-3429.1999 · Cited by 78
Shihabuddin, L. S., Numan, S., Huff, M. R., Dodge, J. C., Clarke, J. L., Macauley, S. L., Yang, W., Taksir, T. V., Parsons, G., Passini, M. A., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3584-04.2004 · Cited by 78
Kasperzyk, J. L., d’Azzo, A., Platt, F. M., Alroy, J., & Seyfried, T. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400411-jlr200 · Cited by 77
Cited by
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Braulke, T., & Bonifacino, J. S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.10.016 · Cited by 811
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kitatani, K., Idkowiak-Baldys, J., & Hannun, Y. A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.006 · Cited by 632
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
Kim, M., Wainwright, H. C., Locketz, M., Bekker, L., Walther, G. B., Dittrich, C., Visser, A., Wang, W., Hsu, F., Wiehart, U., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000079 · Cited by 489
Metadata
- Authors
- Kolter, T., & Sandhoff, K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 1758
- Issue
- 12
- Pages
- 2057-2079
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2165980275
- Cited by
- 367
- References
- 257
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.